$0.00030
Last update: Dec 31, 7:00 PM
Comments
Loading...
THC Therapeutics Stock Guidance | OTC:THCT | Benzinga
THC Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for THC Therapeutics (THCT)?
There have been no specific sales or earnings guidance reported for THC Therapeutics in recent months.
Browse guidance and forecast on all stocks.